{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:00:11Z","timestamp":1784422811417,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpsychires.2025.04.025","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:05:51Z","timestamp":1744733151000},"page":"226-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Niacin skin flushing response in patients with schizophrenia: Associations with the efficacy of modified electroconvulsive therapy and clinical symptoms"],"prefix":"10.1016","volume":"186","author":[{"given":"Bingbing","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangying","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/YCT.0000000000000323","article-title":"Ultrabrief electroconvulsive therapy for manic episodes of bipolar disorder","volume":"32","author":"Anand","year":"2016","journal-title":"J. ECT"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.04.025_bib2","article-title":"Inflammation and JNK's role in niacin-gpr109a diminished flushed effect in microglial and neuronal cells with relevance to schizophrenia","volume":"30","author":"Ansarey","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.04.025_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1441_20","article-title":"Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy","volume":"63","author":"Atagun","year":"2021","journal-title":"Indian J. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib5","first-page":"105","article-title":"Electroconvulsive therapy and its different indications. Dialogues Clin","volume":"10","author":"Baghai","year":"2008","journal-title":"Neurosci"},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2025.04.025_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2004.04.026","article-title":"No evidence for oxidative damage in the hippocampus after acute and chronic electroshock in rats","volume":"1014","author":"Barichello","year":"2004","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2025.04.025_bib7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1023\/B:NERE.0000035811.06277.b3","article-title":"Structure-related oxidative damage in rat brain after acute and chronic electroshock","volume":"29","author":"Barichello","year":"2004","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(70)90086-X","article-title":"Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain","volume":"218","author":"Baz\u00e1n","year":"1970","journal-title":"Biochim. Biophys. Acta."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integratedapproach","volume":"35","author":"Bitanihirwe","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3390\/biom10030384","article-title":"Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia","volume":"10","author":"Bryll","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.04.025_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11920-996-0033-z","article-title":"Treatment-refractory schizophrenia","volume":"3","author":"Buckley","year":"2001","journal-title":"Curr. Psychiatry Rep."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib12","first-page":"278","article-title":"Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients","volume":"43","author":"Buosi","year":"2021","journal-title":"Trends Psychiatry Psychother"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.04.025_bib13","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"issue":"18","key":"10.1016\/j.jpsychires.2025.04.025_bib14","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1080\/14656566.2022.2145884","article-title":"Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia","volume":"23","author":"de Bartolomeis","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jpsychires.2025.04.025_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4684-3276-3_36","article-title":"Phosphatidate, phosphatidylinositol, diacylglycerols, and free fatty acids in the brain following electroshock, anoxia, or ischemia","volume":"83","author":"de Turco","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0091270009332246","article-title":"Effects of aspirin when added to the prostaglandin D 2 receptor antagonist laropiprant on niacin\u2010induced flushing symptoms","volume":"49","author":"Dishy","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/YCT.0000000000000613","article-title":"Clinical effectiveness of maintenance electroconvulsive therapy in patients with schizophrenia: a retrospective cohort study","volume":"36","author":"Isserles","year":"2020","journal-title":"J. ECT"},{"issue":"10323","key":"10.1016\/j.jpsychires.2025.04.025_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12411","article-title":"Efficacy and safety of modified electroconvulsive therapy for the refractory depression in older patients","volume":"12","author":"Jiang","year":"2020","journal-title":"Asia. Pac. Psychiatry."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1005702","article-title":"Peripheral biomarkers of treatment-resistant schizophrenia: genetic, inflammation and stress perspectives","volume":"13","author":"Jiao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.04.025_bib23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.pnpbp.2011.05.007","article-title":"Acute and chronic effectsof electroconvulsive treatment on oxidative parameters in schizophrenia patients","volume":"35","author":"Kartalci","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2025.04.025_bib24","doi-asserted-by":"crossref","unstructured":"Kassay, G. and Mathe, V., 1964. [The effect of thiamine on the electroshock-induced changes of the orientation reflex and of the nicotinic acid reaction in schizophrenics. II]. Acta Neuroveg (Wien).25, 551-9.https:\/\/doi.org\/10.1007\/bf01228442.","DOI":"10.1007\/BF01228442"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","article-title":"Implications for reactive oxygen species in schizophrenia pathogenesis","volume":"176","author":"Koga","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.24869\/psyd.2019.62","article-title":"Maintenance electroconvulsive therapy in schizophrenia","volume":"31","author":"Krepela","year":"2019","journal-title":"Psychiatr. Danub."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/HRP.0000000000000365","article-title":"Electroconvulsive therapy: mechanisms of action, clinical considerations, and future directions","volume":"01;31","author":"Kritzer","year":"2023","journal-title":"Harv. Rev. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.04.025_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.encep.2007.08.008","article-title":"Maintenance electroconvulsive therapy and treatment of refractory schizophrenia","volume":"34","author":"L\u00e9vy-Rueff","year":"2008","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.psychres.2008.10.012","article-title":"Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders","volume":"175","author":"L\u00e9vy-Rueff","year":"2010","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.04.025_bib30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/schbul\/sbac011","article-title":"Impaired membrane lipid homeostasis in schizophrenia","volume":"48","author":"Li","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jad.2023.10.151","article-title":"Omega-3 supplementation improves depressive symptoms, cognitive function and niacin skin flushing response in adolescent depression: a randomized controlled clinical trial","volume":"345","author":"Li","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ijnp\/pyaa003","article-title":"Disturbance of oxidative stress parameters in treatment-resistant bipolar disorder and their association with electroconvulsive therapy response","volume":"23","author":"Lv","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.04.025_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia-an overview","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2025.04.025_bib34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpsychires.2006.02.010","article-title":"Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics","volume":"41","author":"Medina-Hern\u00e1ndez","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/schbul\/16.4.563","article-title":"Defining treatment refractoriness in schizophrenia","volume":"16","author":"Meltzer","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose\u2013response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12944-016-0196-5","article-title":"Detection and treatment of omega-3 fatty acid deficiency in psychiatric practice: rationale and implementation","volume":"15","author":"Messamore","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jpsychires.2025.04.025_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102084","article-title":"An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia","volume":"155","author":"Nadalin","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2025.04.025_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1749-6632.1986.tb51272.x","article-title":"Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness","volume":"462","author":"Post","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2022.07.017","article-title":"Attenuated niacin skin flushing response in children and adolescents with mental disorders: a transdiagnostic early warning marker","volume":"248","author":"Qing","year":"2022","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.jpsychires.2025.04.025_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fpsyt.2020.00731","article-title":"Self-awareness deficits of cognitive impairment in individuals with schizophrenia. Really?","volume":"30","author":"Raffard","year":"2020","journal-title":"Front. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jnr.490180311","article-title":"Arachidonic acid, stearic acid, and diacylglycerol accumulation correlates with the loss of phosphatidylinositol 4,5-bisphosphate in cerebrum 2 seconds after electroconvulsive shock: complete reversion of changes 5 minutes after stimulation","volume":"18","author":"Reddy","year":"1987","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.jpsychires.2025.04.025_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2215-0366(24)00136-6","article-title":"Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis","volume":"11","author":"Salahuddin","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychires.2025.04.025_bib45","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1038\/s41380-023-02232-7","article-title":"Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia","volume":"28","author":"Saleh","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.9758\/cpn.2017.15.1.40","article-title":"Evaluation of oxidative status in patients treated with electroconvulsive therapy","volume":"15","author":"\u015eenyurt","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.04.025_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pnpbp.2006.11.014","article-title":"Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia","volume":"31","author":"Shimizu","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.04.025_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/schbul\/sbz037","article-title":"Electroconvulsive therapy for treatment-resistant schizophrenia","volume":"18;45","author":"Sinclair","year":"2019","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.04.025_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2005.02.007","article-title":"Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia","volume":"72","author":"Smesny","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.04.025_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jad.2009.12.017","article-title":"Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder","volume":"124","author":"Smesny","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.04.025_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2018.08.002","article-title":"ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials","volume":"105","author":"Wang","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.schres.2019.12.044","article-title":"Altered functional connectivity ofthe thalamus induced by modified electroconvulsive therapy for schizophrenia","volume":"218","author":"Wang","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2021.02.009","article-title":"Attenuated and delayed niacin skin flushing inschizophrenia and affective disorders: a potential clinical auxiliary diagnostic marker","volume":"230","author":"Wang","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2025.04.025_bib55","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.psychres.2019.01.095","article-title":"An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia","volume":"273","author":"Xu","year":"2019","journal-title":"Psychiatry Res."},{"issue":"22","key":"10.1016\/j.jpsychires.2025.04.025_bib56","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/0006-2952(75)90110-0","article-title":"Electroconvulsive shock raises prostaglandins F in rat cerebral cortex","volume":"24","author":"Zatz","year":"1975","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.04.025_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156510","article-title":"Electroconvulsive therapy added to non-clozapine antipsychotic medication for treatment resistant schizophrenia: meta-analysis of randomized controlled trials","volume":"11","author":"Zheng","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:54:52Z","timestamp":1777694092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":56,"alternative-id":["S0022395625002602"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.04.025","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niacin skin flushing response in patients with schizophrenia: Associations with the efficacy of modified electroconvulsive therapy and clinical symptoms","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}